Skip to content

From academic roots…

ViaNautis was established in 2018 as SomaServe, a spin-off from UCL by founders Dr Francesca Crawford, Professor Guiseppe Battaglia and Dr Denis Cecchin.

…to a thriving biotech

ViaNautis is now a globally focused biotechnology company advancing its mission to create value through the development of genetic nanomedicines

Our Team

Dr Fran Crawford

Chief Executive Officer
Track record in founding and growing technology companies and BTB/BTC sales, network
Read more

Dr Denis Cecchin

Chief Technical Officer
Skilled in Translational research, research and development, and Business Development.
Read more

Dr. Samuel Barker

Chief Business Officer
Expertise in developing and commercialising innovative platform technologies.
Read more

Ben Stephens

Director of Finance
25 years’ experience at board level finance and operational roles in the Pharma and Industrial sectors.
Read more

Scientific Advisors

Board of Directors

Dr Fran Crawford

Chief Executive Officer
Track record in founding and growing technology companies and BTB/BTC sales, network
Read more

Prof Giuseppe Battaglia

Chief Scientific Officer
Technology inventor and Professor of Molecular Bionics at IBEC in Barcelona
Read more

David Ford

David is an Oxford-based life sciences angel investor.
Read more

Owen Smith

Owen is a Partner at 4BIO Capital.
Read more

Lucy Edwardes-Jones

Member of the BGF Investment Team in Cambridge and the South East
Read more

Steven Biesmans

UCB Ventures Principal
Read more

Tim de Vere Green

Founder Origin Investment Activities
Read more

Join our team

We work hard to deliver innovative science and have a lot of fun along the way. If that is the environment that you are looking for, then we would love to hear from you.

Recruitment Agencies: please do not contact us. We operate a closed preferred supplier list that doesn’t allow agencies to register with us or send CVs to us. This is made up from carefully selected specialist scientific agencies, and we are not looking to add to our suppliers.

Investors

Back To Top